Abstract:Alzheimer's disease (AD) is a progressive neurodegenerative disease marked by the accumulation of amyloid-β (Aβ) plaques and neurofibrillary tangles. Aβ oligomers cause synaptic dysfunction early in AD by enhancing long-term depression (LTD; a paradigm for forgetfulness) via metabotropic glutamate receptor (mGluR)-dependent regulation of striatal-enriched tyrosine phosphatase (STEP 61 ). Reelin is a neuromodulator that signals through ApoE (apolipoprotein E) receptors to protect the synapse against Aβ toxicity (Durakoglugil et al., 2009) Reelin signaling is impaired by ApoE4, the most important genetic risk factor for AD, and Aβ-oligomers activate metabotropic glutamate receptors (Renner et al., 2010). We therefore asked whether Reelin might also affect mGluR-LTD. To this end, we induced chemical mGluR-LTD using DHPG (Dihydroxyphenylglycine), a selective mGluR5 agonist. We found that exogenous Reelin reduces the DHPG-induced increase in STEP 61 , prevents the dephosphorylation of GluA2, and concomitantly blocks mGluR-mediated LTD. By contrast, Reelin deficiency increased expression of Ca 2+ -permeable GluA2-lacking AMPA receptors along with higher STEP 61 levels, resulting in occlusion of DHPG-induced LTD in hippocampal CA1 neurons. We propose a model in which Reelin modulates local protein synthesis as well as AMPA receptor subunit composition through modulation of mGluR-mediated signaling with implications for memory consolidation or neurodegeneration. SIGNIFICANCE STATEMENT Reelin is an important neuromodulator, which in the adult brain controls synaptic plasticity and protects against neurodegeneration. Amyloid-β has been shown to use mGluRs to induce synaptic depression through endocytosis of NMDA and AMPA receptors, a mechanism referred to as LTD, a paradigm of forgetfulness. Our results show that Reelin regulates the phosphatase STEP, which plays an important role in neurodegeneration, as well as the expression of calcium-permeable AMPA receptors, which play a role in memory formation. These data suggest that Reelin uses mGluR LTD pathways to regulate memory formation as well as neurodegeneration.

The Role of Reelin Signaling in Alzheimer’s Disease

Signaling pathways regulating neuron-glia interaction and their implications in Alzheimer's disease.

Signaling Pathways Regulating Neuron–glia Interaction and Their Implications in Alzheimer's Disease

Progress in molecular mechanisms of β-amyloid peptides in alzheimer's disease

Reelin Links Apolipoprotein E4, Tau, and Amyloid-β in Alzheimer’s Disease

Deregulation of Brain Insulin Signaling in Alzheimer’s Disease

The Inflammation-Induced Dysregulation of Reelin Homeostasis Hypothesis of Alzheimer's Disease

The Role of Wnt Signaling in the Development of Alzheimer’s Disease: A Potential Therapeutic Target?

Reduced Reelin expression accelerates amyloid-beta plaque formation and tau pathology in transgenic Alzheimer's disease mice

Role of Cholinergic Signaling in Alzheimer’s Disease

Reelin Regulates Neuronal Excitability through Striatal-Enriched Protein Tyrosine Phosphatase (STEP61) and Calcium Permeable AMPARs in an NMDAR-Dependent Manner

Role of Amyloid Β Protein Receptors in Mediating Synaptic Plasticity.

Role Of Pro-Inflammatory Cytokines Released From Microglia In Alzheimer'S Disease

The Role of APP in Alzheimer’s Disease

The intricate role of CCL5/CCR5 axis in Alzheimer disease

Beta-amyloid impairs reelin signaling

Role of Pro-Inflammatory Cytokines Released from Microglia in Alzheimer's Disease.

The Role of Retromer in Alzheimer’s Disease

Roles of O-GlcNAcylation on amyloid-β precursor protein processing, tau phosphorylation, and hippocampal synapses dysfunction in Alzheimer’s disease

Roles of Beta-Adrenergic Receptors in Alzheimer'S Disease: Implications for Novel Therapeutics

Reelin reverts biochemical, physiological and cognitive alterations in mouse models of Tauopathy